Back to ONCOLYTICS BIOTECH INC

Oncolytics Biotech Inc

All insider transactions

14 transactions

DateMoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Mar 12, 2026BuyCommon SharesKelly Jared
CEO
+5,050$0.96$4.8K114,050low
Mar 11, 2026BuyCommon SharesParsons James T.
Director
+10,000$1.03$10.3K41,849low
Feb 12, 2026BuyCommon SharesSeizinger Bernd R.
Director
+40,000$0.85$33.9K566,991low
Feb 12, 2026BuyCommon SharesPisano Wayne
Director
+30,000$0.84$25.3K492,414low
Feb 12, 2026BuyCommon SharesAndrews Patricia S
Director
+35,400$0.86$30.3K78,128low
Feb 12, 2026BuyCommon SharesLook Kirk
Executive
+12,000$0.84$10.1K287,515low
Feb 12, 2026BuyCommon SharesKelly Jared
CEO
+29,500$0.84$24.8K109,000low
Feb 12, 2026BuyCommon SharesHeineman Thomas Charles
Executive
+12,132$0.83$10.0K282,818low
Feb 12, 2026BuyCommon SharesHagerman Allison
Executive
+10,000$0.83$8.3K115,059low
Feb 12, 2026BuyCommon SharesBrown Deborah Margaret
Director
+25,000$0.85$21.2K109,851low
Feb 11, 2026BuyCommon SharesSeizinger Bernd R.
Director
+60,000$0.83$49.6K526,991low
Feb 11, 2026BuyCommon SharesKelly Jared
CEO
+5,600$0.84$4.7K79,500low
Feb 11, 2026BuyCommon SharesAromando Andrew
Executive
+29,600$0.86$25.4K55,100low
Jan 16, 2026BuyCommon SharesSeizinger Bernd R.
Director
+100,000$1.04$103.8K466,991medium
← PrevPage 1 of 1Next →